Skip to main content

Hepatology International

Ausgabe 2/2019

Inhalt (16 Artikel)

Open Access Guidelines

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Tatsuo Kanda, George K. K. Lau, Lai Wei, Mitsuhiko Moriyama, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geofferey W. McCaughan, Jafri Wasim, Darrell H. G. Crawford, Jia-Horng Kao, Osamu Yokosuka, Shiv Kumar Sarin, Masao Omata

Review Article

Immunological cure of HBV infection

Julia Lang, Christoph Neumann-Haefelin, Robert Thimme

Review Article

Goals and targets for personalized therapy for HCC

Thomas Couri, Anjana Pillai

Review Article

Laser capture microdissection: techniques and applications in liver diseases

Beatriz Aguilar-Bravo, Pau Sancho-Bru

Original Article

Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection

Lung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, Qin Ning, Ka-Shing Cheung, James Fung, Ching-Lung Lai, Man-Fung Yuen

Original Article

Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?

Amr Shaaban Hanafy, Mohamed A. Bassiony, Mohammad Abd Alkhalik Basha

Open Access Original Article

Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India

Ajit Sood, Ajay Duseja, Mayank Kabrawala, Pradeep Amrose, Bhadadev Goswami, Abhijit Chowdhury, Shiv Kumar Sarin, Abraham Koshy, Robert H. Hyland, Sophia Lu, Gregory Camus, Luisa M. Stamm, Diana M. Brainard, G. Mani Subramanian, Madhura Prasad, Shobna Bhatia, Samir R. Shah, Dharmesh Kapoor, Shalimar, Vivek Saraswat

Original Article

Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?

Ashokkumar Jain, Danielle Miller, Ian Schreibman, Thomas R. Riley III, Karen L. Krok, Takehiko Dohi, Rajeev Sharma, Zakiyah Kadry

Original Article

The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting

Shuntaro Obi, Takahisa Sato, Shinpei Sato, Miho Kanda, Yuta Tokudome, Yuichiro Kojima, Yoji Suzuki, Kenji Hosoda, Toshihiro Kawai, Yuji Kondo, Yoshihiro Isomura, Hiroshi Ohyama, Keiko Nakagomi, Hiroshi Ashizawa, Yuko Miura, Hiroyuki Amano, Hitoshi Mochizuki, Masao Omata

Original Article

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016

Donghee Kim, Won Kim, Adeyinka C. Adejumo, George Cholankeril, Sean P. Tighe, Robert J. Wong, Stevan A. Gonzalez, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed

Original Article

Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd–Chiari syndrome on warfarin

Akash Shukla, Abhinav Jain, Vinit Kahalekar, Sheetal Bendkhale, Nithya Gogtay, Urmila Thatte, Shobna Bhatia

Original Article

Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population

Ju Young Jung, Jae-Jun Shim, Sung Keun Park, Jae-Hong Ryoo, Joong-Myung Choi, In-Hwan Oh, Kyu-Won Jung, Hyunsoon Cho, Moran Ki, Young-Joo Won, Chang-Mo Oh

Original Article

Influence of proton pump inhibitors on microbiota in chronic liver disease patients

Kenta Yamamoto, Masatoshi Ishigami, Takashi Honda, Tomoaki Takeyama, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Hidemi Goto, Yoshiki Hirooka

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.